期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

白细胞介素18在急性冠状动脉综合征的研究进展

Research Progress of Interleukin-18 in Acute Coronary Syndrome
下载PDF
导出
摘要 白细胞介素18是多效能前炎性因子,诱导干扰素γ的合成与释放,激活单核巨噬细胞分泌基质金属蛋白酶,增量调节许多细胞因子,对于粥样斑块不稳定、促进急性冠状动脉综合征发生起重要作用,是急性冠状动脉综合征的独立危险因子之一。阻断IL-18/IL-18受体相互作用,可以抑制动脉粥样硬化发展、保持斑块稳定,为防治急性冠状动脉综合征提供新的治疗手段。 Interleukin-18 is a proinfhmmatory cytokine with manifold effect, including inducting IFN-γ synthesis and releasing, activating monocyte/macrophage to secrete MMP and upregulatlng many inflammatory factors, which play an important role in the genesis of unstable atherosclerotic plaque and promoting the genesis of acute coronary syndrome（ ACS）, thus IL-18 is one independent risk factor of ACS. Inhibiting the coaction of IL-18/IL-18 receptor can inhibit the genesis of artherosclerosis, maintain the stability of plaque, which will provide new therapeutic methods for the prevention and therapy of acute coronary syndrome（ACS）.
作者 郭静 唐仁泉 于霄 孙雷
机构地区 抚顺矿务局总医院病理科 大连医科大学病理教研室
出处 《医学综述》 2008年第17期2685-2688,共4页 Medical Recapitulate
关键词 白细胞介素18 动脉粥样硬化 急性冠状动脉综合征 Interleukin-18 Atherosclerosis Acute coronary syndrome
分类号 R543.3 [医药卫生—心血管疾病]
  • 相关文献

参考文献24

  • 1Libby P, Theroux P. Pathophysiology of coronary artery disease [ J]. Circulation,2005,111 ( 25 ) :3481-3488.
  • 2Armstrong E J, Morrow DA, Sabatine MS. Inflammatory biomarkers in acute coronary syndromes [ J ]. Circulation, 2006, 113 ( 6 ): 72-75.
  • 3Okamura H,Tstutsi H, Komatsui H, et al. Cloning of a new cytokine that induces IFN-γ production by T cell [ J ]. Nature, 1995, 378(6552) :88-91.
  • 4Ushio S,Namba M,Okura T,et al. Cloning of the cDNA for human IFN-γ inducing factor, expression in E. coil, and studies on the biologic activities of the protein [ J]. J Immunol, 1996, 156 ( 11 ) : 4274-4279.
  • 5Vermot-Desroches C, Subiger O, Guenot F, et al. Monoclonal antibodies specific for the IL-18 receptor[ J]. Cell Immunol,2005,236 (1/2) :101-104.
  • 6Lebel-Binay S, Berger A, Zinzindohoue F, et al. Interleukin-18 : biological properties and clinical implications [ J ]. Eur Cytokine Netw ,2000,11 ( 1 ) :15-26.
  • 7de Nooijer R, vonder Thusen JH, Verkleij C J, et al. Overexpression of IL-18 decreases intimal collagen content and promotes a vulnerable plaque phenotype in apolipoprotein-E-deficient mice[ J]. Arterioscler Thromb Vasc Biol,2004,24(12) :2313-2319.
  • 8Tenger C, Sundborger A, Jawien J, et al. IL-18 accelerates atherosclerosis accompanied by elevation of IFN-gamma and CXCL16 expression independently of T cells[ J]. Arterioscler Thromb Vasc Biol, 2005,25 ( 4 ) : 655 -657.
  • 9Whitman SC, Ravisankan P, Daugherty A. Interleukin-18 enhances atherosclerosis in apolipoprotein E (-/-) mice through release of interferon-gamma [ J ]. Circ Res, 2002,90 ( 2 ) : E34-38.
  • 10Mallat Z, Corbaz A, Scoazec A, et al. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability [J]. Circulation ,2001,104(14) :1598-1603.

二级参考文献24

  • 1曾春,马中富,赵锋,梁艳冰,詹红,唐皓,熊艳,叶海宁.白细胞介素-18含量变化与急性心肌梗死的炎症关系[J].中国中西医结合急救杂志,2004,11(5):311-313. 被引量：16
  • 2张燕,黎莉,谭红伟,马志勇,王颖,李静.白细胞介素18与急性冠脉综合征的临床研究[J].临床医药实践,2005,14(1):9-11. 被引量：2
  • 3Biasucci LM,Santamana M,Liuizzo G..Inflammation,atherosclerosis and acute coronary syndromes[J].MinerVa Cardioangiol,2002,50(5):475 -486.
  • 4Raykk,CampNJ,Bennett CE,et al.Genetic variation at the interleukin-1 locus is a determinant of changes in soluble endothelial factors in patients with acute coronary syndromes[J].Clin Sci (Lond),2002,103(3):303 -310.
  • 5VohnoutB,Di Castelnuovo A,Trotta R,et al.Interleukin-1 gene cluster polymorphisms and risk of coronary artery disease[J].Haematologica.2003,88 (1):54-60.
  • 6Stephens JW,Humphries SE.The molecular genetics of cardiovascular disease:clinical implications[J].J Intern Med,2003,253(2):120 -127.
  • 7RallidisLS,ZolindakiMG,Manioudaki HS,et al.Prognostic value of C-reactive protein,fibrinogen,interleukin-6,and macrophage colony stimulating factor in severe unstable angina[J].Clin Cardiol,2002,25(11):505 -510.
  • 8Natio Y,TsujinoT,Fujioka Y,et al.Increased circulating interleukin-18 in patients with Congestive heart failure[J].Heart,2002,88(3):296-297.
  • 9Raeburn CD,Dinarello CA,Zimmernan MA,et al.Neutra lization of IL-18 attenuates Lipopolysaccharide-induced myocardial dysfunction[J].Am J Physiol Heart Circ Physiol,2002,283 (2):H650-657.
  • 10Yamaoka-Tojo M,Tojo T,Inomata T,et al.Circulating levels of interleukin-18 reflect etiologies of heart failure:Th1/Th2 cytokine imbalance exaggerates the pathophysiology of advanced heart failure[J].J Card Fail,2002,8(1):21 -27.

共引文献1

医学综述
2008年 第17期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部